Medical News Today
Two large studies from the University of Southern Denmark suggest that the diabetes medication Ozempic doubles the risk of developing NAION, a rare but serious condition that damages the optic nerve.
Drawing on comprehensive data from Danish and Norwegian health registers, the studies validate earlier concerns raised in a smaller American study.
While the absolute risk remains low, researchers suggest the findings should guide discussions between doctors and patients about the benefits and risks of treatment with Ozempic.
Two research teams conducted separate studies using different methods to analyze all Danish users of Ozempic.
Follow the link below to read the full story om Medical News Today:
Information source: https://www.medicalnewstoday.com